Standout Papers

Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Bl... 2013 2026 2017 2021 554
  1. Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy (2014)
    Dmitriy Zamarin, Rikke Holmgaard et al. Science Translational Medicine
  2. Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4 (2013)
    Rikke Holmgaard, Dmitriy Zamarin et al. The Journal of Experimental Medicine
  3. Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner (2015)
    Rikke Holmgaard, Dmitriy Zamarin et al. Cell Reports

Immediate Impact

24 by Nobel laureates 34 from Science/Nature 95 standout
Sub-graph 1 of 16

Citing Papers

Engineered skin bacteria induce antitumor T cell responses against melanoma
2023 StandoutScience
Metabolic barriers to cancer immunotherapy
2021 Standout
33 intermediate papers

Works of Rikke Holmgaard being referenced

Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 Nobel
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
and 2 more

Author Peers

Author Last Decade Papers Cites
Rikke Holmgaard 1423 1314 85 505 45 2.5k
Nicholas N. Vahanian 760 676 84 583 68 1.8k
Angelos D. Gritzapis 754 1418 294 805 70 2.8k
Joannes F.M. Jacobs 1621 2007 90 1134 94 3.8k
Sahil Adriouch 666 1023 110 1018 71 3.2k
Protul Shrikant 2109 3182 120 1135 47 4.4k
Armelle Prévost‐Blondel 1368 1819 54 657 46 2.7k
Yan Zheng 938 1885 344 934 49 3.2k
Shunsuke Chikuma 1797 2609 210 966 56 4.2k
Stefano Ugel 2016 3188 173 1070 60 4.4k
Giuseppina Bonanno 680 846 397 1051 52 2.5k

All Works

Loading papers...

Rankless by CCL
2026